Negotiable securities code: Abbreviation of 603387 negotiable securities: Base number of egg biology announcement: 2019-039
Our company board of directors and collectivity trustee make sure this announcement content is nonexistent state of sex of any false account, misdirect is major perhaps omit, assume to the authenticity of its content, accuracy and integrality reach joint liability individually.
Serious content hints:
Invest the name of mark: Mexico base limited company of egg biology science and technology (provisional name)
Invest amount and scale: Register capital 5 million dollar, among them: Base Inc. of egg biology science and technology (the following abbreviation " company " ) contributive 3.5 million dollar, contributive scale 70% ; LuSys Laboratories, inc. (Lu laboratory company, the following abbreviation " Lu lab " ) contributive 1.5 million dollar, contributive scale 30% .
This second invest external establish control share company, still need national hair to change appoint, the examination of the concerned branch such as commerce director branch, exchange control branch and Mexico are corresponding approve or obtain of governmental orgnaization put on record register; This second investment establishs control share company, face the risk of the respect such as industry risk, market risk, management venture possibly in real operation process.
The sale outside the condition reachs the situation of the investment outside the condition: End 2018 3 quarters, the proportion that the sales revenue outside company condition holds company business gross earnings is 3.24% ; End to show day to this announcement, the company already created wholy-owned subsidiary in the United States, register capital to be 500 thousand dollar, the research and development that major servicing is an advanced technique and introduce; The company plans to be established in India control share company (detailed sees announcement 2018-112) , the company plans to invest 95 thousand dollar, major servicing is the sale that the product diagnoses outside body, at present India accuses share company to still be examined and approve in Department of Commerce in, already finished nuclear name to work in place, register a data basically to already was referred, company general discloses progress case according to the requirement of relevant law laws and regulations.
One, invest an overview external
1, the globalization overall arrangement that develops the strategy and product, research and development, market to advance globalization, development America market, perfect construction of overseas sale network, in cogent safeguard advocate the premise of steady progress issues business Wu, the company drafts as joint as Lu lab investment to be established in Mexico control share company, register capital 5 million dollar, among them: The company is contributive 3.5 million dollar, contributive scale 70% ; Lu lab is contributive 1.5 million dollar, contributive scale 30% . This second investment agreement had be notted sign formally.
2, on March 25, 2019, the company held thirteenth of the 2nd board of directors second conference, discuss passed " what control share company about be in Mexico to establish is second reading " , this investment item is restricted in decision making authority of company board of directors inside, need not refer company shareholder plenary meeting to discuss, but this investment still needs relevant government sector to examine and approve. Layer of management of accredit of company board of directors is responsible and specific deal with this second investment to establish Mexican subsidiary matters concerned, include but not be confined to is dealt with about the branch to the country examine and approve put on record, deal with register register wait for formalities.
3, this second establish accuse share company proceeding not to involve correlation to trade, also do not form " appear on the market company gross assets recombines administrative measure " major asset of the regulation recombines.
2, cooperate square fundamental condition
1, company name: LuSys Laboratories, inc. Lu laboratory company (California, santiago)
2, register capital: 1 million dollar
3, register an address: 10054 Mesa Ridge Ct.Suite 118, san Diego, CA 92121
4, legal representative: Lu Weizhao Dr.Edward Lu
5, company property: Finite liability joint-stock company
6, scope of operations: Cancer of the technical research inside domain of biology science and technology, tumour, content of heart disease mark, catch a disease, disease of department of gynaecology, medicaments abuse, vitamin D, of pet disease detect quickly with diagnose.
7, did not form between Lu lab and company " stock of Shanghai stock exchange appears on the market regular " related concern of the regulation.
3, the fundamental condition that invests mark
1, company name: Mexico base limited company of egg biology science and technology (provisional name, specific name is called with the name of approve accurate)
2, register an address: Wanner of Mexican the base of a fruit
3, register capital: 5 million dollar (the company is contributive 3.5 million dollar, contributive scale 70% ; Lu lab is contributive 1.5 million dollar, contributive scale 30% . )
4, company type: Finite liability joint-stock company
5, legal representative: Lu Weizhao
6, scope of operations: The technology of science and technology of biology, biochemistry seeks advice, development, development, production and sale
7, contributive means: Company own reserves
Specific subsidiary name, register capital, register address, scope of operations to wait with Mexican place approve of the industrial and commercial mechanism that register is accurate.
4, the purpose that invests external and the influence to the company
(one) the purpose that invests external
This second investment basically is the need of strategy of company whole world. Mexico is the important country of North America, company and Lu lab are joint-stock, main purpose is the innovation product that fits Euramerican market in American research and development, the product of stimulative company and Lu lab and resource are formed complementary, use advantage of Mexican labor cost to build support of market research and development, production, sale, technology to be equal to unifinication group in Mexican place, be helpful for a company developing the business of North America area, accelerate company internationalization to develop a process.
(2) the influence to the company
Company investment establishs afore-mentioned accusing share company can help a company extend America market on one hand, satisfy the need that company strategy admits, can form with the product of Lu lab on the other hand complementary, the integrated competition actual strength that can increase a company fights risk ability with what the company manages. Fund that creates subsidiary all be company own reserves, won't produce undesirable effect to operation result, nonexistent damage appear on the market the case of company and shareholder interest.
5, the risk analysis that invests external
This second in Mexico investment is established control share company, the company basically is accepted the risk of the respect such as wave motion of policy, Mexican place policy and social environment, exchange rate by Mexican photograph custom duty, environment of the jurisprudence to Mexico, business and culture atmosphere need strengthen the company understanding. In the meantime, the company needs farther understanding and familiar Mexico commerce and investment jurisprudence, make sure law of Mexico of Mexican subsidiary according to closes legally compasses run, avoid to run the legal risk of the generation in the process.
This second invest item to still need national hair to change external appoint, the examination of the concerned branch such as commerce director branch, exchange control branch and Mexico are corresponding approve or obtain of governmental orgnaization put on record register, still put in certain uncertainty.
Company early days establishs India of company of similar situation husband to accuse share company to still be in Department of Commerce to examine and approve in, already finished nuclear name to work in place, register a data basically to already was referred, the company will press the provision that reflects relevant law, code and normative sex file strictly, according to the progress circumstance of follow-up item, fulfill information in time to disclose obligation, please broad investor notices to invest a risk.
6, for future reference file
Base Inc. of egg biology science and technology thirteenth of the 2nd board of directors second conference resolution.
Hereby announcement.
Base Inc. of egg biology science and technology
Board of directors
On March 25, 2019
